Acute Porphyria Drug Database

N06BC01 - Caffeine
Propably not porphyrinogenic
PNP

Rationale
Metabolised by CYP 1A2. Widely used as beverage but no reports of porphyrinogenic effects. One reference:
Chemical description
(To be edited, initial data ST OCT 04) Xantine derivative used as a stimulant and headache analgesic. Metabolized by CYP1A2. Inhibitor of CYP 1A2.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes N06B / N06BC or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙